Home › NDC Lookup › RxCUI directory › RxCUI 2052605

Tacrolimus 0.2 MG Granules for Oral Suspension — RxCUI 2052605

Name: Tacrolimus 0.2 MG Granules for Oral Suspension (RxCUI 2052605)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2052605 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2052605

Official nameTacrolimus 0.2 MG Granules for Oral Suspension

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped6

Package NDCs mapped6

Reported Medicaid activity (SDUD)8,270 prescriptions · 27 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tacrolimus: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

That's a great question, and it's one of the most important things to understand. Your body's immune system doesn't just stop trying to attack the new organ once you leave the hosp...
Why do I have to take tacrolimus even when I feel completely fine?
It actually does matter — but the key is being consistent, not choosing one over the other. Food can change how much tacrolimus your body absorbs, so if you always take it the same...
Does it matter if I take tacrolimus with food or on an empty stomach?

📖 Read our full Tacrolimus guide →

🕸️ Concept Web — How Tacrolimus 0.2 MG Granules for Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Tacrolimus 0.2 MG Granules for Oral Suspension RxCUI 2052605 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Tacrolimus 42316 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Prograf 196463 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Tacrolimus Granules for Oral Suspension 2052604 SCDF
- Tacrolimus Granule Product 2052603 SCDG
- Tacrolimus Oral Product 1164202 SCDG
- Tacrolimus Granules for Oral Suspension [Prograf] 2052607 SBDF
- Prograf Granule Product 2052608 SBDG
- Prograf Oral Product 1180663 SBDG
- Granules for Oral Suspension 1540454 DF
- Granule Product 1294708 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Tacrolimus 0.2 MG 2052503 SCDC
- Tacrolimus 0.2 MG Granules for Oral Suspension [Prograf] 2052609 SBD
- Tacrolimus 0.2 MG [Prograf] 2052606 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Tacrolimus 0.2 MG SCDC · 2052503
Tacrolimus Granules for Oral Suspension SCDF · 2052604
Tacrolimus Granule Product SCDG · 2052603
Tacrolimus Oral Product SCDG · 1164202

Brand-Name Concepts

Tacrolimus 0.2 MG Granules for Oral Suspension [Prograf] SBD · 2052609
Tacrolimus 0.2 MG [Prograf] SBDC · 2052606
Tacrolimus Granules for Oral Suspension [Prograf] SBDF · 2052607
Prograf Granule Product SBDG · 2052608
Prograf Oral Product SBDG · 1180663
Prograf BN · 196463

📦 FDA Products & Package NDCs

6 products · 6 package NDCs

6 package NDCs map to RxCUI 2052605 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00469-0607-73	1 BOTTLE in 1 CARTON (0469-0607-73) / 100 CAPSULE, GELATIN...	Prograf	Astellas Pharma US, Inc.	1998-08-24
00469-0617-73	1 BOTTLE in 1 CARTON (0469-0617-73) / 100 CAPSULE, GELATIN...	Prograf	Astellas Pharma US, Inc.	1994-04-08
00469-0657-73	1 BOTTLE in 1 CARTON (0469-0657-73) / 100 CAPSULE, GELATIN...	Prograf	Astellas Pharma US, Inc.	1994-04-08
00469-1230-50	50 PACKET in 1 CARTON (0469-1230-50) / 1 GRANULE, FOR SUSPE...	Prograf	Astellas Pharma US, Inc.	2018-05-24
00469-1330-50	50 PACKET in 1 CARTON (0469-1330-50) / 1 GRANULE, FOR SUSPE...	Prograf	Astellas Pharma US, Inc.	2018-05-24
00469-3016-01	10 AMPULE in 1 BOX (0469-3016-01) / 1 mL in 1 AMPULE	Prograf	Astellas Pharma US, Inc.	1994-04-08

Observed labelers: Astellas Pharma US, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J7507	Tacrolimus imme rel oral 1mg	3	CMS
J7521	Tacrolim granules oral susp	2	CMS
J7525	Tacrolimus injection	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.